Daniel Ginnetti Net Worth

The estimated Net Worth of Daniel Ginnetti is at least $6.25 Million dollars as of 15 March 2024. Mr. Ginnetti owns over 6,600 units of Stericycle stock worth over $2,603,646 and over the last 10 years he sold SRCL stock worth over $2,252,525. In addition, he makes $1,391,790 as Executive Vice President - International at Stericycle.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Ginnetti SRCL stock SEC Form 4 insiders trading

Daniel has made over 28 trades of the Stericycle stock since 2014, according to the Form 4 filled with the SEC. Most recently he exercised 6,600 units of SRCL stock worth $407,022 on 15 March 2024.

The largest trade he's ever made was selling 24,291 units of Stericycle stock on 7 June 2021 worth over $1,848,302. On average, Daniel trades about 3,028 units every 70 days since 2014. As of 15 March 2024 he still owns at least 42,219 units of Stericycle stock.

You can see the complete history of Mr. Ginnetti stock trades at the bottom of the page.

Daniel Ginnetti biography

Daniel V. Ginnetti serves as Executive Vice President - International of the Company. He was named Executive Vice President, International in June 2019 having previously served as Chief Financial Officer from August, 2014. He joined Stericycle as Area Vice President of Finance in 2003. In 2004 he was promoted to Area Vice President for Stericycle’s Western, and later, Midwestern business units. Following that, he was promoted to Senior Vice President of Operations for the U.S. and Canada. He returned to financial management in 2013, becoming Vice President of Corporate Finance and then CFO in August 2014. Prior to joining Stericycle, Mr. Ginnetti previously served in various finance and accounting positions with The Ralph M. Parsons Company, a worldwide engineering firm, and Ryan Herco Products Corp., a national industrial plastics distributor. Mr. Ginnetti received his bachelor’s degree from the University of California, Santa Barbara.

What is the salary of Daniel Ginnetti?

As the Executive Vice President - International of Stericycle, the total compensation of Daniel Ginnetti at Stericycle is $1,391,790. There are 3 executives at Stericycle getting paid more, with Cindy Miller having the highest compensation of $3,215,910.

How old is Daniel Ginnetti?

Daniel Ginnetti is 51, he's been the Executive Vice President - International of Stericycle since 2019. There are 21 older and 5 younger executives at Stericycle. The oldest executive at Stericycle Inc. is Veronica Hagen, 74, who is the Independent Director.

What's Daniel Ginnetti's mailing address?

Daniel's mailing address filed with the SEC is 2355 WAUKEGAN ROAD, , BANNOCKBURN, IL, 60015.

Insiders trading at Stericycle

Over the last 22 years, insiders at Stericycle have traded over $161,740,081 worth of Stericycle stock and bought 27,280 units worth $1,574,920 . The most active insiders traders include Jack W Schuler, John Connaughton, and James Reid Anderson. On average, Stericycle executives and independent directors trade stock every 23 days with the average trade being worth of $835,752. The most recent stock trade was executed by Jesse Joel Jr Hackney on 16 May 2024, trading 3,620 units of SRCL stock currently worth $223,245.

What does Stericycle do?

stericycle is a global services company. we provide highly specialized solutions serving healthcare organizations and commercial businesses of every size and shape. throughout the last 25 years, we have grown from a small start-up in medical waste management into a leader across a range of increasingly complex and highly regulated arenas, such as: • brand protection solutions • environmental & sustainable solutions • patient & customer communication solutions • regulated waste management & compliance solutions from the start we have challenged the status quo of what a business solution can be. by identifying unmet needs, we have redefined and transformed multiple industries from a narrowly defined service category to a robust suite of solutions that customers need and want. our success with this strategy has landed stericycle among the fortune 1000 list and forbes 25 most innovative companies. a publicly-traded company with $2.5 billion in 2014 revenue, our core purpose is to

Complete history of Mr. Ginnetti stock trades at Stericycle

Stericycle executives and stock owners

Stericycle executives and other stock owners filed with the SEC include:

• Cindy Miller,
  President, Chief Executive Officer, Director
• Cindy J. Miller,
  Pres, CEO & Director
• Janet H. Zelenka,
  Exec. VP, CFO & Chief Information Officer
• Daniel Ginnetti,
  Executive Vice President - International
• Janet Zelenka,
  Chief Financial Officer, Executive Vice President, Chief Information Officer
• Kurt Rogers,
  Executive Vice President, General Counsel and Corporate Secretary
• Joseph Reuter,
  Executive Vice President and Chief People Officer
• Stephen Cory White,
  Exec. VP & Chief Commercial Officer
• Kurt M. Rogers,
  Exec. VP, Gen. Counsel & Corp. Sec.
• Robert Murley,
  Independent Chairman of the Board
• Brian Anderson,
  Independent Director
• Lynn Bleil,
  Independent Director
• Michael Zafirovski,
  Independent Director
• Kay Priestly,
  Independent Director
• Veronica Hagen,
  Independent Director
• Thomas Chen,
  Independent Director
• J. Joel Hackney,
  Independent Director
• Stephen Hooley,
  Independent Director
• S. Cory White,
  Executive Vice President and Chief Commercial Officer
• Richard Moore,
  Executive Vice President - North American Operations
• Dominic Culotta,
  Executive Vice President and Chief Engineer
• Michael Weisman,
  Executive Vice President, Chief Ethics and Compliance Officer
• Richard Michael Moore,
  Exec. VP of North American Operations
• Joseph Anthony Reuter,
  Exec. VP & Chief People Officer
• Michael S. Weisman,
  Exec. VP and Chief Ethics & Compliance Officer
• Andrew Ellis,
  VP of Investor Relations
• Daniel V. Ginnetti,
  Exec. VP of International
• Jennifer Koenig,
  VP of Corp. Communications & Investor Relations
• Richard Joseph Hoffman,
  Sr. VP & Chief Accounting Officer
• Richard J Hoffman,
  SVP & CHIEF ACCOUNTING OFFICER
• John P Schetz,
  Sr Counsel M & A
• Thomas D Brown,
  Director
• Mike S Zafirovski,
  Director
• John Patience,
  Director
• Jack W Schuler,
  Chairman
• Brenda R Frank,
  EVP & Chief People Officer
• Brent Arnold,
  President, USA/Canada
• Ruth Ellen Abdulmassih,
  Executive Vice President
• Rodney F Dammeyer,
  Director
• Charles A Alutto,
  President, USA
• Robert Guice,
  Executive Vice President, Intl
• David W. Stahl,
  EVP and CIO
• William J. Seward,
  EVP, Chief Commercial Officer
• James Reid Anderson,
  Director
• Mark C Miller,
  CEO
• Michael J Collins,
  President, Pharma Services
• Shan Sacranie,
  Exec Vice Pres International
• Richard L Foss,
  EXVP
• Richard T Kogler,
  COO
• Richard J Marasco,
  Exec VP Corp Mergers & Acquis
• Thomas R Reusche,
  Director
• L John Wilkerson,
  Director
• Jonathan T Md Lord,
  Director
• Peter Vardy,
  Director
• Brink Frank Jm Ten,
  CFO
• William K Hall,
  Director
• Ronald G Spaeth,
  Director
• Patrick F Graham,
  Director
• Anthony J Tomasello,
  Vice President
• James J Martell,
  Director
• John Connaughton,
  Director
• James L Welch,
  
• Victoria L Dolan,
  
• Naren K Gursahaney,